Home - Products - Others - Other Targets - (D-Pro4,D-Trp7·9·10)-Substance P (4-11)

(D-Pro4,D-Trp7·9·10)-Substance P (4-11)

CAS No. 86917-57-9

(D-Pro4,D-Trp7·9·10)-Substance P (4-11)( ——— )

Catalog No. M40452 CAS No. 86917-57-9

[D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    (D-Pro4,D-Trp7·9·10)-Substance P (4-11)
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.
  • Description
    [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    86917-57-9
  • Formula Weight
    1207.43
  • Molecular Formula
    C62H74N14O10S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bailey SJ, et al. Effect of the tachykinin antagonist, D-Pro4, D-Trp7,9,10 substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):296-300. ?
molnova catalog
related products
  • Acetyl-(Nle4,Asp5,D-...

    SHU 9119 is a potent human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partial MC5R agonist; with IC50 values of 0.23, 0.06, and 0.09 nM for human MC3R, MC4R and MC5R, respectively.

  • 2-Aminofluorene

    2-Aminofluorene is a biochemical.

  • Chikusetsusaponin IV

    Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.